Tag

GMP Archives - J&K Consulting

General

Digitally supported Production of Medical Cannabis – European Biotechnology | Vol. 19 2020

Read our latest article from European Biotechnology | Spring Edition | Vol. 19 | 2020 A challenge whose success lies in efficient process management and digital development! The times of digitalisation and Industry 4.0 do not stop at the production of medical cannabis for the pharmaceutical industry. The combination of IT-systems and blockchain-based processes allows the value-added chain to be automated and the data generated to be mapped in a tamper-proof manner. by Hannah Maria Lambertz, Consultant und Quality Manager…
1. October 2020
General

“The COVID-19 impact was not all bad” – European Biotechnology | Vol. 19 2020

Read our latest article from European Biotechnology | Autumn Edition | Vol. 19 | 2020 Rainer Krüger, European Cannabis Association and CEO of J&K Consulting GmbH, explains how product and process standards for medical cannabis can be set. Did we arouse your interest and you would like to have further information? We gladly be available for you. You can reach us through our contact page.
27. September 2020
General

MABEWO AG presents the Pharma-Dome project and inspires Maltese authorities

A MABEWO delegation led by CEO Jörg Trübl visited Malta in mid-July to present the project of a pharmaceutical dome on site at "Malta Enterprise". Malta Enterprise is the local agency for economic development and foreign direct investments and therefore the first contact for MABEWO AG for project approval. The delegation was received by Mr. Kurt Farruga, Managing Director of Malta Enterprise, and the Minister of Health, Hon. Deo Debattista. Read the complete MABEWO newsletter with interview by Rainer Krüger…
15. August 2020
General

GACP and GMP support

Did we arouse your interest and you would like to have further information? We gladly be available for you. You can reach us through our contact page.
22. July 2019
General

Step into the medicinal cannabis business – What is your level of cultivation?

To enter the world of Pharma you must go through certain development stages to fully comply with Good Manufacturing Practice (GMP). All these stages are driven by minimizing patient risk. Therefore, a risk-based quality system needs to be established. Patient’s safety is the overall aim of GMP guidelines, whose compliance is inspected by the authorities. To fullfil authorities’ demand you need safe and reproducible products. By clicking on the following  button, you have the ability to download our questionnaire that…
7. June 2019
General

Medicinal Cannabis under GACP and GMP – A look into the future is worth a thought

von Jessica Grote When thinking about cultivating medicinal cannabis, most people see the easy money that seems to be within one’s reach. New facilities are built up that are designed to support optimal plant growth. People think about the correct water, light and air supply, but what stays a side effect is to design their facility according to GMP and GACP requirements.Another very important point often not taken into account is a look into the future. How will the facility…
18. April 2019